|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.990 SEK | +3.33% |
|
+3.33% | -33.41% |
| 07/07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 01/07 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
| Market Cap | 99.53M 10.49M 9.08M 8.49M 7.76M 14.62M 1B 14.85M 39.06M 500M 39.39M 38.53M 1.67B | P/E 2026 * |
-2.94x | P/E 2027 * | -2.15x |
|---|---|---|---|---|---|
| Enterprise Value | 91.53M 9.65M 8.35M 7.81M 7.13M 13.44M 920M 13.65M 35.92M 460M 36.22M 35.43M 1.53B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
52.67% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | +3.33% | ||
| 1 week | +3.33% | ||
| Current month | +7.28% | ||
| 1 month | +6.39% | ||
| 3 months | +7.79% | ||
| 6 months | -8.27% | ||
| Current year | -33.41% |
| 1 week | 8.55 |  | 9.04 |
| 1 month | 7.6 | | 9.04 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 28 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 302.9 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/3/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/3/22 | Others | Chairman | 120,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.33% | +3.33% | -63.90% | -64.95% | 10.49M | |
| +3.90% | +9.86% | +96.91% | +136.30% | 1,098B | |
| +0.99% | +2.91% | +51.05% | +52.06% | 631B | |
| +0.78% | +1.17% | +25.21% | +63.74% | 438B | |
| +1.58% | +4.80% | +51.42% | +39.79% | 368B | |
| +0.65% | +1.85% | +34.81% | +39.99% | 298B | |
| +0.79% | +4.26% | +9.78% | +7.42% | 251B | |
| +1.52% | +10.12% | +44.75% | +59.20% | 226B | |
| +0.34% | +1.27% | -5.23% | -50.94% | 209B | |
| -0.11% | +1.46% | +11.43% | +66.32% | 165B | |
| Average | +1.38% | +2.87% | +25.62% | +34.89% | 368.43B | |
| Weighted average by Cap. | +1.80% | +4.82% | +52.19% | +68.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.27M -2.83M -2.64M -2.42M -4.55M -312M -4.62M -12.16M -156M -12.27M -12M -519M | -46M -4.85M -4.2M -3.92M -3.59M -6.76M -462M -6.86M -18.05M -231M -18.2M -17.81M -770M |
| Net Debt | -8M -843K -730K -682K -624K -1.17M -80.41M -1.19M -3.14M -40.23M -3.17M -3.1M -134M | -10M -1.05M -912K -853K -779K -1.47M -101M -1.49M -3.92M -50.28M -3.96M -3.87M -167M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/08/26 | SEK 8.990 | +3.33% | 22,689 |
| 07/08/26 | SEK 8.700 | -1.36% | 13,151 |
| 06/08/26 | SEK 8.820 | -1.56% | 7,538 |
| 05/08/26 | SEK 8.960 | +0.45% | 9,640 |
| 04/08/26 | SEK 8.920 | +2.53% | 11,025 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Select your edition
All financial news and data tailored to specific country editions
